Meike Hutt

Person

Schomdorf, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Engineered T cell receptors and immune therapy using the same
- Patent number 11,932,689
- Issue date Mar 19, 2024
- Immatics Biotechnologies GmbH
- Felix Unverdorben
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen binding proteins specifically binding PRAME
- Patent number 11,859,009
- Issue date Jan 2, 2024
- Immatics Biotechnologies GmbH
- Gabriele Pszolla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antigen binding proteins specifically binding MAGE-A
- Patent number 11,840,577
- Issue date Dec 12, 2023
- Immatics Biotechnologies GmbH
- Meike Hutt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antigen binding protein against HER3
- Patent number 11,008,402
- Issue date May 18, 2021
- UNIVERSITAT STUTTGART
- Roland Kontermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engineered T cell receptors and immune therapy using the same
- Patent number 10,889,645
- Issue date Jan 12, 2021
- Immatics Biotechnologies GmbH
- Felix Unverdorben
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engineered T cell receptors and immune therapy using the same
- Patent number 10,618,956
- Issue date Apr 14, 2020
- Immatics Biotechnologies GmbH
- Felix Unverdorben
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Serum half-life extension using IgBD
- Patent number 10,428,120
- Issue date Oct 1, 2019
- Universitat Stuttgart
- Roland Kontermann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-chain tumor necrosis factor (TNF) ligand family molecules, f...
- Patent number 10,428,149
- Issue date Oct 1, 2019
- Universitat Stuttgart
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
- Publication number 20240228611
- Publication date Jul 11, 2024
- Immatics Biotechnologies GmbH
- Felix UNVERDORBEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A
- Publication number 20240117068
- Publication date Apr 11, 2024
- Immatics Biotechnologies GmbH
- Meike HUTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME
- Publication number 20240092933
- Publication date Mar 21, 2024
- Immatics Biotechnologies GmbH
- Gabriele PSZOLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A
- Publication number 20240052054
- Publication date Feb 15, 2024
- Immatics Biotechnologies GmbH
- Meike HUTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME
- Publication number 20230357428
- Publication date Nov 9, 2023
- Immatics Biotechnologies GmbH
- Gabriele PSZOLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE
- Publication number 20230203200
- Publication date Jun 29, 2023
- Immatics Biotechnologies GmbH
- Gabriele PSZOLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME
- Publication number 20230091330
- Publication date Mar 23, 2023
- Immatics Biotechnologies GmbH
- Gabriele PSZOLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME
- Publication number 20220372165
- Publication date Nov 24, 2022
- Immatics Biotechnologies GmbH
- Gabriele PSZOLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
- Publication number 20210101975
- Publication date Apr 8, 2021
- Immatics Biotechnologies GmbH
- Felix UNVERDORBEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES
- Publication number 20210048442
- Publication date Feb 18, 2021
- Immatics Biotechnologies GmbH
- Heiko SCHUSTER
- G01 - MEASURING TESTING
Information Patent Application
RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE
- Publication number 20210032370
- Publication date Feb 4, 2021
- Immatics Biotechnologies GmbH
- Gabriele PSZOLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A
- Publication number 20210032361
- Publication date Feb 4, 2021
- Immatics Biotechnologies GmbH
- Meike HUTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
- Publication number 20200207849
- Publication date Jul 2, 2020
- Immatics Biotechnologies GmbH
- Felix UNVERDORBEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
- Publication number 20190135914
- Publication date May 9, 2019
- Immatics Biotechnologies GmbH
- Felix UNVERDORBEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE-CHAIN TNF LIGAND FAMILY MOLECULES AND FUSION PROTEINS AND DE...
- Publication number 20180094059
- Publication date Apr 5, 2018
- UNIVERSITAT STUTTGART
- Ugur SAHIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SERUM HALF-LIFE EXTENSION USING IGBD
- Publication number 20170145062
- Publication date May 25, 2017
- UNIVERSITAT STUTTGART
- Roland Kontermann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERUM HALF-LIFE EXTENSION USING IGBD
- Publication number 20140220017
- Publication date Aug 7, 2014
- Roland Kontermann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Engineered T cell receptors and immune therapy using the same

Antigen binding proteins specifically binding PRAME

Antigen binding proteins specifically binding MAGE-A

Antigen binding protein against HER3

Engineered T cell receptors and immune therapy using the same

Engineered T cell receptors and immune therapy using the same

Serum half-life extension using IgBD

Single-chain tumor necrosis factor (TNF) ligand family molecules, f...

Patents Applicationslast 30 patents

NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES

RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A

NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

SINGLE-CHAIN TNF LIGAND FAMILY MOLECULES AND FUSION PROTEINS AND DE...

SERUM HALF-LIFE EXTENSION USING IGBD

SERUM HALF-LIFE EXTENSION USING IGBD